• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHB2001401 沙格列汀二甲双胍缓释片(III) metformin hydrochloride;saxagliptin Tablet, extended release Chemical Drugs Supplementary Application 2020-08-21 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Filed 2020-09-02 view
JYHB1801265 沙格列汀二甲双胍缓释片(III) metformin hydrochloride;saxagliptin Tablet, extended release Chemical Drugs Supplementary Application 2018-10-24 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Filed 2018-10-25 view
JXHS1300101 沙格列汀二甲双胍缓释片(III) metformin hydrochloride;saxagliptin Tablet, extended release Chemical Drugs Import Drug Application 2013-12-05 AstraZeneca AB AstraZeneca AB Certificate Issued 2017-05-22 view
JYHF1700055 沙格列汀二甲双胍缓释片(III) metformin hydrochloride;saxagliptin Tablet, extended release Chemical Drugs Supplementary Application 2017-06-22 阿斯利康制药有限公司 Astrazeneca Pharmaceutical Co Ltd Certificate Issued 2017-08-01 view
JYHB1801512 沙格列汀二甲双胍缓释片(III) metformin hydrochloride;saxagliptin Tablet, extended release Chemical Drugs Supplementary Application 2019-01-28 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2019-09-29 view
JYHB1700835 沙格列汀二甲双胍缓释片(III) metformin hydrochloride;saxagliptin Tablet, extended release Chemical Drugs Supplementary Application 2017-06-21 阿斯利康制药有限公司 Astrazeneca Pharmaceutical Co Ltd Certificate Issued 2018-06-04 view
JYHB1801509 沙格列汀二甲双胍缓释片(III) metformin hydrochloride;saxagliptin Tablet, extended release Chemical Drugs Supplementary Application 2019-01-28 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2019-09-29 view
JYHB1700743 沙格列汀二甲双胍缓释片(III) metformin hydrochloride;saxagliptin Tablet, extended release Chemical Drugs Supplementary Application 2017-06-05 阿斯利康制药有限公司 Astrazeneca Pharmaceutical Co Ltd Certificate Issued 2017-07-17 view
JYHB2001836 沙格列汀二甲双胍缓释片(III) metformin hydrochloride;saxagliptin Tablet, extended release Chemical Drugs Supplementary Application 2020-09-21 阿斯利康制药有限公司 Astrazeneca Pharmaceutical Co Ltd Filed 2020-10-12 view
JYHB1801266 沙格列汀二甲双胍缓释片(III) metformin hydrochloride;saxagliptin Tablet, extended release Chemical Drugs Supplementary Application 2018-10-24 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Filed 2018-10-25 view
CYHS2401832 沙格列汀二甲双胍缓释片(Ⅲ) metformin hydrochloride;saxagliptin Tablet, extended release Chemical Drugs(4) Generic Drug 2024-06-19 Hefei Pingguang Pharmaceutical Co Ltd view
CYHS2302891 沙格列汀二甲双胍缓释片(III) metformin hydrochloride;saxagliptin Tablet, extended release Chemical Drugs(4) Generic Drug 2023-10-25 Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd view
CYHS2404005 沙格列汀二甲双胍缓释片(III) metformin hydrochloride;saxagliptin Tablet, extended release Chemical Drugs(4) Generic Drug 2024-11-21 ShanxiTongda Pharmaceutical Co Ltd view
CYHS2200072 沙格列汀二甲双胍缓释片(III) metformin hydrochloride;saxagliptin Tablet, extended release Chemical Drugs(4) Generic Drug 2022-01-13 Beijing Foyou Pharma Co Ltd view
CYHS2402533 沙格列汀二甲双胍缓释片(III) metformin hydrochloride;saxagliptin Tablet, extended release Chemical Drugs(4) Generic Drug 2024-08-08 view
CYHS2401959 沙格列汀二甲双胍缓释片(Ⅲ) metformin hydrochloride;saxagliptin Tablet, extended release Chemical Drugs(4) Generic Drug 2024-06-29 Shandong Zibo Xinda Pharmaceutical Co Ltd view
JYHB2300378 沙格列汀二甲双胍缓释片(Ⅲ) metformin hydrochloride;saxagliptin Tablet, extended release Chemical Drugs Supplementary Application 2023-07-08 view
JYHZ2100559 沙格列汀二甲双胍缓释片(Ⅲ) metformin hydrochloride;saxagliptin Tablet, extended release Chemical Drugs License Renew 2021-06-09 view
JYHB2300375 沙格列汀二甲双胍缓释片(Ⅲ) metformin hydrochloride;saxagliptin Tablet, extended release Chemical Drugs Supplementary Application 2023-07-08 view
CYHB2401052 沙格列汀二甲双胍缓释片(Ⅲ) metformin hydrochloride;saxagliptin Tablet, extended release Chemical Drugs(4) Supplementary Application 2024-07-16 Beijing Foyou Pharma Co Ltd view